| scholarly article | Q13442814 |
| P50 | author | Shawn M. Gomez | Q41049180 |
| Zefeng Wang | Q55154444 | ||
| P2093 | author name string | Yihsuan S Tsai | |
| Daniel Dominguez | |||
| P2860 | cites work | An automated method for finding molecular complexes in large protein interaction networks | Q21284295 |
| WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer | Q22254002 | ||
| CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth | Q24296787 | ||
| The Cancer Genome Atlas Pan-Cancer analysis project | Q24606808 | ||
| The Bcl-2 apoptotic switch in cancer development and therapy | Q24620437 | ||
| Splicing regulation: from a parts list of regulatory elements to an integrated splicing code | Q24642620 | ||
| RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation | Q39044270 | ||
| GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. | Q39099776 | ||
| A complex network of factors with overlapping affinities represses splicing through intronic elements | Q39225814 | ||
| Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules | Q39277603 | ||
| Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. | Q39335846 | ||
| Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma | Q39540908 | ||
| HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer | Q39763266 | ||
| Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. | Q43559520 | ||
| The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases | Q57912086 | ||
| Misregulation of pre-mRNA alternative splicing in cancer | Q27007114 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
| Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
| CD44 in cancer | Q28217782 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome | Q29547458 | ||
| Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing | Q29547470 | ||
| Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments | Q29614452 | ||
| Understanding alternative splicing: towards a cellular code | Q29615085 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| Predictive identification of exonic splicing enhancers in human genes | Q29618621 | ||
| Identification of genes periodically expressed in the human cell cycle and their expression in tumors | Q29619131 | ||
| Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion | Q30423199 | ||
| The splicing activator DAZAP1 integrates splicing control into MEK/Erk-regulated cell proliferation and migration. | Q34097169 | ||
| Deconstructing the molecular portraits of breast cancer | Q34154147 | ||
| The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression | Q34157516 | ||
| MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. | Q34189334 | ||
| Engineering splicing factors with designed specificities | Q34235465 | ||
| Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance | Q34536974 | ||
| Analysis and design of RNA sequencing experiments for identifying isoform regulation | Q34565989 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| The RNA-binding protein QKI suppresses cancer-associated aberrant splicing | Q35145133 | ||
| Aberrant and alternative splicing in cancer | Q35936123 | ||
| The gene encoding the splicing factor SF2/ASF is a proto-oncogene | Q36129226 | ||
| Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. | Q36446169 | ||
| RNA sequencing of cancer reveals novel splicing alterations | Q36782437 | ||
| NMD: a multifaceted response to premature translational termination | Q37675497 | ||
| Alternative splicing: a pivotal step between eukaryotic transcription and translation | Q38079475 | ||
| Hallmarks of alternative splicing in cancer | Q38171229 | ||
| A day in the life of the spliceosome | Q38180972 | ||
| The alternative splicing side of cancer. | Q38198391 | ||
| Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas | Q38967517 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transcriptome | Q252857 |
| P304 | page(s) | 6825-6839 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors | |
| P478 | volume | 6 |
| Q37010219 | A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation |
| Q33687737 | Allelic imbalance of somatic mutations in cancer genomes and transcriptomes. |
| Q38735423 | Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems |
| Q42754639 | An extensive program of periodic alternative splicing linked to cell cycle progression |
| Q26801191 | Circulating RNAs as new biomarkers for detecting pancreatic cancer |
| Q47790761 | Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events. |
| Q36473639 | Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma |
| Q36991152 | Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma |
| Q92296632 | Genetic basis of functional variability in adhesion G protein-coupled receptors |
| Q92450883 | Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors |
| Q39368650 | RNA processing as an alternative route to attack glioblastoma. |
| Q92025312 | Roles and mechanisms of alternative splicing in cancer - implications for care |
| Q50074498 | SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis. |
| Q37000093 | SURVIV for survival analysis of mRNA isoform variation |
| Q92067653 | Survival-associated alternative splicing signatures in soft tissue sarcomas |
| Q55449946 | Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells. |
| Q58802939 | Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma |
| Q57049086 | psichomics: graphical application for alternative splicing quantification and analysis |
Search more.